Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 960 of 5804
-
Experimental immune cell cocktail targets tough lymphoma
Disease control Not yet recruitingThis research study is for people who have relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) that has not responded to two or more lines of therapy. The purpose of this study is to identify the recommended dose of allogeneic NK cells in combination with IL-2, Tafasitamab…
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New combo therapy aims to prevent lung damage in tiniest preemies
Disease control Not yet recruitingThis clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.
Phase: PHASE1, PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI-Powered lifestyle app aims to ease Parkinson's symptoms
Symptom relief Not yet recruitingLifestyle interventions can alleviate Parkinson's Disease (PD) symptoms and delay disease progression. The novelty of this project lies in the development of an innovative smart platform that utilizes artificial intelligence (AI) and predictive models to offer a groundbreaking so…
Sponsor: University Ramon Llull • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Scientists map hidden brain layers to unlock new treatments
Knowledge-focused Not yet recruitingThis is a basic science study of a missing dimension of human brain function, how information flows the six layers of the brain. The research will involve neurosurgery patients and controls in laminar-resolution functional MRI at 7 Tesla during a working memory and language task.…
Sponsor: Christopher I. Petkov • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Can a common heart drug stop PTSD before it starts?
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate the effect of early propranolol administration on the occurrence of post-traumatic stress disorder (PTSD) symptoms at five weeks in adult female victims of sexual violence. The investigators hypothesize that propranolol administrati…
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
Eye exams could end guesswork in depression treatment
Knowledge-focused Not yet recruitingMajor depressive disorder (MDD) is a frequent and particularly disabling disorder. The efficacy of current antidepressants is limited, with 50-60% of patients not achieving a sufficient response to treatment. Indeed, to date, clinicians are unable to predict the therapeutic respo…
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
One blood transfusion could prevent ventilator setbacks in ICU
Disease control Not yet recruitingIn comparison with a liberal transfusion strategy (high haemoglobin threshold), a restrictive transfusion strategy leads to around 50% decrease in the total number of transfused red blood cells (RBC) units and 30% to 40% fewer transfused patients, without any difference in mortal…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Brain stent trial aims to ease pressure headaches and save sight
Disease control Not yet recruitingThe objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Phase: NA • Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a common drug curb polyps in teens with rare genetic condition?
Disease control Not yet recruitingThe hypothesize of this research is that rapamycin is effective and well-tolerated in teenagers with familial adenomatous polyposis (FAP). Rapamycin could be effective in blocking the formation of adenomas and/or their evolution by decreasing their size and number. Researchers ai…
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for hard-to-treat pancreatic cancer?
Disease control Not yet recruitingThis is a phase Ib, open-label study to evaluate safety and efficacy of NRT6008 in combination with standard-of-care chemotherapy in patients with unresectable Locally Advanced Pancreatic Carcinoma (LAPC).
Phase: PHASE1 • Sponsor: NRT MedTech Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could ketamine ease severe BPD symptoms? new pilot study aims to find out
Symptom relief Not yet recruitingThe main objective of this pilot study is to evaluate at D9 the evolution of BPD symptoms' intensity(scale BSL-23) in severe BPD patients, after two Ketamine infusions (0.5mg/kg at H0 and H24). The intervention is combined with the first level standard of care : Good Psychiatric …
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Could Neighbor-to-Neighbor first aid save lives in cameroon?
Knowledge-focused Not yet recruitingCameroon experiences a high burden of injury-related morbidity and mortality and currently lacks a formal pre-hospital care system. Lay First Responder (LFR) programs have been implemented in several low-and middle-income countries to improve early injury care by training non-med…
Phase: NA • Sponsor: Sabrinah Christie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Which Pre-CAR-T chemo is safer? new trial aims to find out
Disease control Not yet recruitingBendamustine and the combination of fludarabine/cyclophosphamide are fully authorized chemotherapy agents in Switzerland for lymphoma treatment and currently used in routine clinical practice as lymphodepletion strategy before CAR-T immunotherapy, as supported by retrospective st…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug may offer safer, faster fix for Post-Surgery heart flutter
Disease control Not yet recruitingPost-operative atrial fibrillation is a common problem post cardiac surgery with rates exceeding 30%. Atrial fibrillation has multiple adverse effects on cardiac hemodynamics and can lead to hypotension, diminished end organ perfusion and lengthen the stay in ICU. Amiodarone is t…
Phase: PHASE3 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Brain zap study probes inflammation link in Parkinson's
Knowledge-focused Not yet recruitingThe aim of the study is to characterize the neuroinflammatory effects of subthalamic deep brain stimulation in patients with Parkinson's disease, by analyzing changes in blood neuroinflammatory and neurodegenerative biomarkers before and after surgery (at 6 and 12 months, respect…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Simple exercises may boost nerve repair in diabetic neuropathy
Disease control Not yet recruitingThis study will examine how two types of exercise programs affect nerve health in people with diabetic peripheral neuropathy. Diabetic peripheral neuropathy is a common complication of type 2 diabetes that can cause numbness, pain, balance problems, and reduced quality of life. E…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nurse-Led mobile clinics aim to tame high blood pressure in liberia
Disease control Not yet recruitingThe goal of this study is to learn if a nurse-led, task-shifting, community-based program can help lower blood pressure in adults aged 25 and older with uncontrolled high blood pressure (hypertension) in Monrovia, Liberia. The program is delivered through community-based mobile c…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Sleep drug could quiet breathing pauses in apnea
Disease control Not yet recruitingThe goal of this clinical trial is to investigate the 1-month treatment effects of different dose of lemborexant in moderate OSA adult patients (18-65 years of age) with low arousal threshold. The main questions it aims to answer are: Primary outcome measure: Apnea/hypopnea ind…
Phase: PHASE1, PHASE2 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Shockwave therapy may ease stubborn achilles pain
Symptom relief Not yet recruitingBACKGROUND Achilles tendinopathy-pain in the Achilles tendon-is a common and often long-lasting condition that limits physical activity and performance, and also affects work capacity and quality of life. The pain is localized either to the mid- portion of the tendon or at its in…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Lab-Grown lung tumors could reveal why some drugs work and others fail
Knowledge-focused Not yet recruitingThe PRECISE-EGFR study is a prospective, observational project designed to generate patient-derived in vitro models (cell cultures and organoids) from individuals with non-small cell lung cancer (NSCLC) carrying EGFR mutations. These models will be used to evaluate sensitivity to…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC